Great Valley Advisor Group Inc. bought a new position in Livent Co. (NYSE:LTHM – Get Rating) in the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 26,235 shares of the company’s stock, valued at approximately $640,000.
Several other hedge funds and other institutional investors also recently modified their holdings of LTHM. Marshall Wace LLP purchased a new stake in shares of Livent during the 1st quarter worth $52,000. First Trust Advisors LP purchased a new stake in shares of Livent during the 1st quarter worth $1,710,000. Amundi Pioneer Asset Management Inc. purchased a new stake in shares of Livent during the 1st quarter worth $798,000. Morgan Stanley increased its position in Livent by 44.7% during the 2nd quarter. Morgan Stanley now owns 1,884,049 shares of the company’s stock valued at $36,475,000 after buying an additional 582,130 shares in the last quarter. Finally, Advisor Group Holdings Inc. increased its position in Livent by 22.1% during the 3rd quarter. Advisor Group Holdings Inc. now owns 51,509 shares of the company’s stock valued at $1,192,000 after buying an additional 9,328 shares in the last quarter. Hedge funds and other institutional investors own 97.33% of the company’s stock.
Several research analysts recently issued reports on the company. The Goldman Sachs Group reduced their target price on Livent from $23.00 to $20.00 and set a “sell” rating on the stock in a research report on Tuesday, March 1st. Deutsche Bank Aktiengesellschaft assumed coverage on Livent in a research report on Tuesday. They set a “hold” rating and a $29.00 target price on the stock. Cowen raised Livent from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 4th. Zacks Investment Research lowered Livent from a “buy” rating to a “hold” rating in a research report on Friday, February 18th. Finally, TheStreet raised Livent from a “c” rating to a “b-” rating in a report on Wednesday, May 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $29.23.
Livent (NYSE:LTHM – Get Rating) last posted its earnings results on Tuesday, May 3rd. The company reported $0.21 EPS for the quarter, topping the consensus estimate of $0.14 by $0.07. The firm had revenue of $143.50 million for the quarter, compared to analyst estimates of $139.92 million. Livent had a return on equity of 8.69% and a net margin of 11.56%. Livent’s revenue for the quarter was up 56.5% compared to the same quarter last year. During the same period last year, the company earned $0.02 earnings per share. Equities analysts expect that Livent Co. will post 1.23 EPS for the current year.
Livent Profile (Get Rating)
Livent Corporation manufactures and sells performance lithium compounds primarily used in lithium-based batteries, specialty polymers, and chemical synthesis applications in North America, Latin America, Europe, the Middle East, Africa, and the Asia Pacific. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and butyllithium, which is used in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in non-rechargeable batteries and the production of lightweight materials for aerospace applications.
- Get a free copy of the StockNews.com research report on Livent (LTHM)
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Dynatrace: Fundamentals are Positive While Being Punished
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.